Integrated database construction of genomic information and clinical information obtained by clinical sequence
Not Applicable
Recruiting
- Conditions
- Malignant tumor
- Registration Number
- JPRN-UMIN000034153
- Lead Sponsor
- Chiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Cases judged inappropriate by the attending physician.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Percentage of cases in which clinical sequences were received, with actionable mutation (unapproved for genetic mutation and with matching drugs including investigational drugs) 2) Percentage of patients who selected treatment based on clinical sequence results 3) Treatment outcome of case 2) 4) Frequency of accidental findings and secondary findings 5) In addition, the sequence success rate, the frequency of genetic mutation for all cases, the frequency of genetic mutation in carcinomas, the relationship between sequence results and survival time, etc. are extensively studied.
- Secondary Outcome Measures
Name Time Method